Compare BLCO & SNEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BLCO | SNEX |
|---|---|---|
| Founded | 1853 | 1924 |
| Country | Canada | United States |
| Employees | N/A | 5400 |
| Industry | Ophthalmic Goods | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 4.9B |
| IPO Year | 2022 | 1996 |
| Metric | BLCO | SNEX |
|---|---|---|
| Price | $16.41 | $105.62 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 2 |
| Target Price | $18.55 | ★ $122.00 |
| AVG Volume (30 Days) | ★ 452.1K | 319.9K |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.50 |
| Revenue | $5,101,000,000.00 | ★ $132,378,200,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.52 | $3.69 |
| P/E Ratio | ★ N/A | $42.10 |
| Revenue Growth | 6.47 | ★ 32.53 |
| 52 Week Low | $10.45 | $65.58 |
| 52 Week High | $18.92 | $132.57 |
| Indicator | BLCO | SNEX |
|---|---|---|
| Relative Strength Index (RSI) | 37.97 | 37.32 |
| Support Level | $16.35 | $92.71 |
| Resistance Level | $16.81 | $131.46 |
| Average True Range (ATR) | 0.51 | 4.84 |
| MACD | -0.22 | -2.83 |
| Stochastic Oscillator | 9.80 | 13.77 |
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
StoneX Group Inc is a Global brokerage and financial services firm. Its service offerings are execution, OTC / Market-Making, advisory services, Global payment solutions, market intelligence, Physical Trading and clearing services. The firm operates in four segments: Commercial, Institutional, Self-Directed/Retail, and Payments. Its customers include governmental and nongovernmental organizations, commercial banks, brokers, institutional investors, and investment banks. The company operates in the United States, South America, Europe, the Middle East and Asia, and other countries, out of which the majority of revenue is generated from the Middle East and Asia Region.